Supplement
Vitamin D is a vitamin your skin makes in sunlight, which the body uses like a hormone to absorb calcium and support bones and immune defenses. People mostly look at it to keep their levels adequate, since shortfalls are common worldwide, and the evidence is strong for that role; trials also found fewer falls and better bone density. The bone density findings rest on small studies, so the evidence there is only moderate.
Sources: PMID 28768407; PMID 19797342; PMID 39640483
- Updated
- How we grade
- 100 studies cited
- Best evidence
- Grade A
- Conditions studied
- 73
- Outcomes
- 308
- Graded outcomes
- 3112215
Evidence by condition
- Strong
- Moderate
- Limited
- Very limited
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Fall Risk Moderate Improvement | Improves (the measure goes down) | Moderate effect | 3 studies | 2,426 people | ||
Studies that measured fall risk
| ||||||
| Functionality in Elderly or Injured | Improves (the measure goes up) | 1 study | 688 people | |||
Studies that measured functionality in elderly or injured | ||||||
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Pre-Eclampsia Risk Moderate Improvement | Improves (the measure goes down) | Moderate effect | 1 study | 5,035 people | ||
Studies that measured pre-eclampsia risk | ||||||
| Preterm Birth Risk | Changes; see studies | 6,055 people | ||||
Pregnancy and Delivery Health
- Pre-Eclampsia Risk: improves
- Preterm Birth Risk: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Pre-Eclampsia Risk Moderate Improvement | Improves (the measure goes down) | Moderate effect | 1 study | 5,035 people | ||
Studies that measured pre-eclampsia risk | ||||||
| Preterm Birth Risk | Changes; see studies | 6,055 people | ||||
Vitamin D Deficiency
- Depression Symptoms: improves
- Fibromyalgia Symptoms: improves
Common Cold
- Influenza Risk: improves
- Upper Respiratory Tract Infection Risk: changes; see studies
- Upper Respiratory Tract Infection Symptoms: improves
Type 2 Diabetes
- Blood glucose: improves
- Depression Symptoms: improves
- Glycemic Control: improves
Premenstrual Syndrome (PMS)
- Anxiety Symptoms: improves
- Depression Symptoms: improves
- Cramps: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Anxiety Symptoms Small Improvement | Improves (the measure goes down) | Small effect | 2 studies | 346 people | ||
Studies that measured anxiety symptoms | ||||||
| Depression Symptoms | Improves (the measure goes down) | 5 studies | 58 people | |||
Studies that measured depression symptoms
| ||||||
| Cramps | Improves (the measure goes down) | 1 study | 897 people | |||
| Total Antioxidant Capacity (TAC) | Improves (the measure goes up) | 1 study | 44 people | |||
Studies that measured total antioxidant capacity (tac) | ||||||
| Fatigue Symptoms | Improves (the measure goes down) | 130 people | ||||
| Interleukin 10 | Improves (the measure goes up) | 44 people | ||||
| Interleukin 12 | Improves (the measure goes up) | 44 people | ||||
| PMS Symptoms | Improves (the measure goes down) | 1,287 people | ||||
Osteoporosis
- Bone Mineral Density: improves
- Fracture Risk: changes; see studies
- Bone-specific Alkaline Phosphatase: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Bone Mineral Density Small Improvement | Improves (the measure goes up) | Small effect | 2 studies | 5,522 people | ||
Studies that measured bone mineral density
| ||||||
| Fracture Risk | Changes; see studies | 1 study | 42,279 people | |||
Studies that measured fracture risk | ||||||
| Bone-specific Alkaline Phosphatase | Improves (the measure goes up) | 8,058 people | ||||
Nonalcoholic Fatty Liver Disease (NAFLD)
- Blood glucose: improves
- Insulin: changes; see studies
- Low-density lipoprotein (LDL): improves
Metabolic Syndrome
- Blood glucose: improves
- Insulin: changes; see studies
- Low-density lipoprotein (LDL): improves
Mood Improvement
- Anxiety Symptoms: improves
- Depression Symptoms: improves
Depression
- Combined Anxiety & Depression: improves
- Depression Symptoms: improves
Migraine Headache
- Migraine Frequency: improves
- Migraine Severity: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Migraine Frequency Small Decrease | Improves (the measure goes down) | Small effect | 122 people | |||
| Migraine Severity | Improves (the measure goes down) | 122 people |
Parkinson's Disease
- 6-Minute Walking Test Performance: improves
- Parkinson's Disease Symptoms: improves
- Walking Ability: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| 6-Minute Walking Test Performance Small Improvement | Improves (the measure goes up) | Small effect | 191 people | |||
| Parkinson's Disease Symptoms | Improves (the measure goes down) | 1 study | 518 people | |||
| Walking Ability | Improves (the measure goes up) | 191 people |
Major Depressive Disorder (MDD)
- Depression Symptoms: improves
- Glycemic Control: improves
- Insulin: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Depression Symptoms Small Improvement | Improves (the measure goes down) | Small effect | 5 studies | 40 people | ||
| Glycemic Control | Improves (the measure goes up) | 4 studies | 40 people | |||
| Insulin | Changes; see studies | 3 studies | 40 people |
Acute Respiratory Infection (ARI)
- Asthma Symptoms: improves
- Upper Respiratory Tract Infection Risk: changes; see studies
- COPD Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Asthma Symptoms Small Improvement | Improves (the measure goes down) | Small effect | 2 studies | 11,321 people | ||
| Upper Respiratory Tract Infection Risk | Changes; see studies | 13 studies | 3,958 people | |||
| COPD Symptoms | Improves (the measure goes down) | 11,321 people | ||||
| Lower Respiratory Tract Infection Risk | Changes; see studies | 10,993 people |
Endometriosis
- Blood glucose: improves
- Glycemic Control: improves
- Insulin: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose Small Improvement | Improves (the measure goes down) | Small effect | 2 studies | 60 people | ||
| Glycemic Control | Improves (the measure goes up) | 4 studies | 60 people | |||
| Insulin | Changes; see studies | 3 studies | 60 people | |||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 3 studies | 60 people | |||
| Endometriosis-associated pelvic pain | Improves (the measure goes down) | 1 study | 108 people | |||
| Insulin Resistance | Improves (the measure goes down) | 1 study | 60 people | |||
| Pelvic Pain | Improves (the measure goes down) | 1 study | 510 people | |||
| Total Antioxidant Capacity (TAC) | Improves (the measure goes up) | 1 study | 60 people | |||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 60 people | ||||
| Dyschezia | Improves (the measure goes up) | 60 people | ||||
| Dysmenorrhea Symptoms | Improves (the measure goes down) | 99 people | ||||
| Dyspareunia | Improves (the measure goes up) | 60 people | ||||
| Glutathione (GSH) | Improves (the measure goes up) | 60 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 60 people | ||||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 60 people | ||||
| Total cholesterol | Improves (the measure goes down) | 60 people | ||||
| Total-/HDL-cholesterol ratio | Changes; see studies | 60 people | ||||
| Triglycerides | Improves (the measure goes down) | 60 people | ||||
| vLDL-C | Improves (the measure goes down) | 60 people |
Flu
- Asthma Symptoms: improves
- Upper Respiratory Tract Infection Symptoms: improves
- Influenza Risk: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Asthma Symptoms Small Improvement | Improves (the measure goes down) | Small effect | 2 studies | 334 people | ||
| Upper Respiratory Tract Infection Symptoms | Improves (the measure goes down) | 13 studies | 332 people | |||
| Influenza Risk | Changes; see studies | 2 studies | 1,482 people | |||
| Fever | Improves (the measure goes up) | 1 study | 334 people | |||
| Pneumonia Symptoms | Improves (the measure goes down) | 1 study | 334 people |
General Cardiovascular Health
- Blood Pressure: improves
- Low-density lipoprotein (LDL): improves
- Risk Of Cardiovascular Disease: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood Pressure Small Improvement | Improves (the measure goes down) | Small effect | 2 studies | 12,749 people | ||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 3 studies | 105 people | |||
| Risk Of Cardiovascular Disease | Improves (the measure goes down) | 3 studies | 57,201 people | |||
| Inflammation | Improves (the measure goes down) | 2 studies | 34 people | |||
| Cardiovascular Disease Mortality | Improves (the measure goes down) | 28,366 people | ||||
| Hematocrit | Improves (the measure goes up) | 105 people | ||||
| Hemoglobin | Improves (the measure goes up) | 105 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 105 people | ||||
| Red Blood Cell Count | Improves (the measure goes up) | 105 people | ||||
| Vascular Function | Improves (the measure goes up) | 34 people |
Polycystic Ovary Syndrome (PCOS)
- Blood glucose: improves
- Insulin: changes; see studies
- Low-density lipoprotein (LDL): improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose Small Improvement | Improves (the measure goes down) | Small effect | 2 studies | 691 people | ||
| Insulin | Changes; see studies | 3 studies | 691 people | |||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 3 studies | 691 people | |||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 691 people | ||||
| Total cholesterol | Improves (the measure goes down) | 691 people | ||||
| Triglycerides | Improves (the measure goes down) | 691 people | ||||
| vLDL-C | Improves (the measure goes down) | 691 people |
Graves’ Disease
- Bone Mineral Density: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Bone Mineral Density Small Improvement | Improves (the measure goes up) | Small effect | 2 studies | 86 people |
Bone Health
- Bone turnover markers: improves
- Calcium Absorption: improves
- Fracture Risk: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Bone turnover markers Small Improvement | Improves (the measure goes down) | Small effect | 1 study | 91 people | ||
| Calcium Absorption | Improves (the measure goes up) | 1 study | 64 people | |||
| Fracture Risk | Changes; see studies | 1 study | 42,279 people | |||
| Parathyroid Hormone | Improves (the measure goes up) | 1 study | 64 people |
Breast Cancer
- Aromatase-Inhibitor Related Joint Pain: improves
- Breast Cancer Risk: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Aromatase-Inhibitor Related Joint Pain Small Improvement | Improves (the measure goes down) | Small effect | 1 study | 60 people | ||
| Breast Cancer Risk | Changes; see studies | 2 studies | 3,861 people |
Primary Dysmenorrhea (Menstrual Cramps)
- Cramps: improves
- Pelvic Pain: improves
- PMS Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Cramps Small Improvement | Improves (the measure goes down) | Small effect | 1 study | 897 people | ||
| Pelvic Pain | Improves (the measure goes down) | 1 study | 510 people | |||
| PMS Symptoms | Improves (the measure goes down) | 897 people |
Muscle Size Strength
- Interleukin 5: improves
- Power Output: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Interleukin 5 Small Increase | Improves (the measure goes up) | Small effect | 1 study | 30 people | ||
| Power Output | Improves (the measure goes up) | 1 study | 20 people |
General Athletic Performance
- Interleukin 5: improves
- Power Output: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Interleukin 5 Small Increase | Improves (the measure goes up) | Small effect | 1 study | 30 people | ||
| Power Output | Improves (the measure goes up) | 1 study | 20 people |
Infant Health
- Liver Enzymes: improves
- Upper Respiratory Tract Infection Risk: changes; see studies
- Parathyroid Hormone: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Liver Enzymes Moderate Improvement | Improves (the measure goes down) | Moderate effect | 1 study | 230 people | ||
| Upper Respiratory Tract Infection Risk | Changes; see studies | 13 studies | 230 people | |||
| Parathyroid Hormone | Improves (the measure goes up) | 1 study | 230 people |
Muscle Size & Strength
- Interleukin 5: improves
- Power Output: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Interleukin 5 Small Increase | Improves (the measure goes up) | Small effect | 1 study | 30 people | ||
| Power Output | Improves (the measure goes up) | 1 study | 20 people |
Upper Respiratory Tract Infection
- Bacterial Infection: improves
- Body Fat: improves
- Upper Respiratory Tract Infection Risk: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Bacterial Infection Moderate Improvement | Improves (the measure goes up) | Moderate effect | 140 people | |||
| Body Fat Small Decrease | Improves (the measure goes down) | Small effect | 25 people | |||
| Upper Respiratory Tract Infection Risk | Changes; see studies | 13 studies | 18,909 people | |||
| Upper Respiratory Tract Infection Symptoms | Improves (the measure goes down) | 13 studies | 2,971 people | |||
| Influenza Risk | Changes; see studies | 2 studies | 2,003 people | |||
| Weight | Improves (the measure goes down) | 2 studies | 25 people | |||
| Fever | Improves (the measure goes up) | 1 study | 164 people | |||
| Muscle Mass | Improves (the measure goes up) | 1 study | 25 people | |||
| Cough | Changes; see studies | 164 people | ||||
| Lower Respiratory Tract Infection Risk | Changes; see studies | 5,110 people |
Immune Health
- Body Fat: improves
- Upper Respiratory Tract Infection Risk: changes; see studies
- Upper Respiratory Tract Infection Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Body Fat Small Decrease | Improves (the measure goes down) | Small effect | 165 people | |||
| Upper Respiratory Tract Infection Risk | Changes; see studies | 13 studies | 152 people | |||
| Upper Respiratory Tract Infection Symptoms | Improves (the measure goes down) | 13 studies | 68 people | |||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 3 studies | 165 people | |||
| Interleukin 5 | Improves (the measure goes up) | 1 study | 30 people | |||
| Parathyroid Hormone | Improves (the measure goes up) | 1 study | 165 people | |||
| Tuberculosis Symptoms | Improves (the measure goes down) | 1 study | 120 people | |||
| Metabolic Rate | Improves (the measure goes up) | 165 people | ||||
| TNF-Alpha | Improves (the measure goes down) | 165 people | ||||
| Triglycerides | Improves (the measure goes down) | 165 people |
Coronary Artery Disease (CAD)
- Body Fat: improves
- Low-density lipoprotein (LDL): improves
- Risk Of Cardiovascular Disease: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Body Fat Small Decrease | Improves (the measure goes down) | Small effect | 165 people | |||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 3 studies | 165 people | |||
| Risk Of Cardiovascular Disease | Improves (the measure goes down) | 3 studies | 2,988 people | |||
| Weight | Improves (the measure goes down) | 2 studies | 165 people | |||
| Parathyroid Hormone | Improves (the measure goes up) | 1 study | 165 people | |||
| Metabolic Rate | Improves (the measure goes up) | 165 people | ||||
| TNF-Alpha | Improves (the measure goes down) | 165 people | ||||
| Triglycerides | Improves (the measure goes down) | 165 people |
Tuberculosis (TB)
- Height: improves
- Tuberculosis risk: changes; see studies
- Tuberculosis Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Height Small Increase | Improves (the measure goes up) | Small effect | 120 people | |||
| Tuberculosis risk | Changes; see studies | 1 study | ||||
| Tuberculosis Symptoms | Improves (the measure goes down) | 1 study | 120 people |
High Cholesterol
- Body Fat: improves
- Low-density lipoprotein (LDL): improves
- Weight: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Body Fat Small Decrease | Improves (the measure goes down) | Small effect | 165 people | |||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 3 studies | 165 people | |||
| Weight | Improves (the measure goes down) | 2 studies | 165 people | |||
| Parathyroid Hormone | Improves (the measure goes up) | 1 study | 165 people | |||
| Metabolic Rate | Improves (the measure goes up) | 165 people | ||||
| TNF-Alpha | Improves (the measure goes down) | 165 people | ||||
| Triglycerides | Improves (the measure goes down) | 165 people |
Sleep Health
- Fatigue Symptoms: improves
- Sleep Duration: improves
- Sleep Latency: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Fatigue Symptoms Small Improvement | Improves (the measure goes down) | Small effect | 93 people | |||
| Sleep Duration | Improves (the measure goes up) | 1 study | 93 people | |||
| Sleep Latency | Improves (the measure goes down) | 93 people | ||||
| Sleep Quality | Improves (the measure goes up) | 93 people |
Weight Loss & Maintenance
- Body Fat: improves
- Low-density lipoprotein (LDL): improves
- Weight: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Body Fat Small Decrease | Improves (the measure goes down) | Small effect | 165 people | |||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 3 studies | 165 people | |||
| Weight | Improves (the measure goes down) | 2 studies | 165 people | |||
| Parathyroid Hormone | Improves (the measure goes up) | 1 study | 165 people | |||
| Metabolic Rate | Improves (the measure goes up) | 165 people | ||||
| TNF-Alpha | Improves (the measure goes down) | 165 people | ||||
| Triglycerides | Improves (the measure goes down) | 165 people |
Menopause
- Inflammation
- Vascular Function: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Inflammation No effect | NoneNo effect | 2 studies | 34 people | |||
| Vascular Function | Improves (the measure goes up) | 34 people |
COVID-19
- All-Cause Mortality
- COVID-19 Severity: improves
- Length of hospitalization: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| All-Cause Mortality No effect | NoneNo effect | 1 study | 5,806 people | |||
| COVID-19 Severity | Improves (the measure goes down) | 3 studies | 385 people | |||
| Length of hospitalization | Improves (the measure goes down) | 2 studies | 944 people | |||
| Need for mechanical ventilation | Changes; see studies | 2 studies | 2,435 people | |||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 1,492 people | ||||
| Ferritin | Improves (the measure goes up) | 1,492 people | ||||
| Hemoglobin | Improves (the measure goes up) | 1,492 people | ||||
| intensive care unit admission risk | Changes; see studies | 4,936 people | ||||
| intubation risk | Changes; see studies | 4,936 people | ||||
| Lymphocyte Count | Improves (the measure goes up) | 1,492 people | ||||
| Neutrophil Count | Improves (the measure goes up) | 1,492 people | ||||
| Serum Platelets | Improves (the measure goes up) | 447 people |
Irritable Bowel Syndrome (IBS)
- Irritable Bowel Syndrome Symptoms
- Plasma Vitamin D: improves
- Quality of Life: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Irritable Bowel Syndrome Symptoms No effect | NoneNo effect | 1 study | 685,802 people | |||
| Plasma Vitamin D | Improves (the measure goes up) | 780 people | ||||
| Quality of Life | Improves (the measure goes up) | 685,802 people |
Pneumonia
- Pneumonia Symptoms
- Upper Respiratory Tract Infection Risk: changes; see studies
- Upper Respiratory Tract Infection Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Pneumonia Symptoms No effect | NoneNo effect | 1 study | 653 people | |||
| Upper Respiratory Tract Infection Risk | Changes; see studies | 13 studies | 453 people | |||
| Upper Respiratory Tract Infection Symptoms | Improves (the measure goes down) | 13 studies | 453 people |
Cardiovascular Disease
- All-Cause Mortality
- Risk Of Cardiovascular Disease: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| All-Cause Mortality No effect | NoneNo effect | 1 study | 3,258 people | |||
| Risk Of Cardiovascular Disease | Improves (the measure goes down) | 3 studies | 3,258 people |
Chronic Liver Disease
- All-Cause Mortality
- Insulin: changes; see studies
- Insulin Resistance: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| All-Cause Mortality No effect | NoneNo effect | 1 study | 4,084 people | |||
| Insulin | Changes; see studies | 3 studies | 4,084 people | |||
| Insulin Resistance | Improves (the measure goes down) | 1 study | 4,084 people | |||
| Liver Enzymes | Changes; see studies | 1 study | 4,084 people | |||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 4,084 people | ||||
| Liver Fat | Improves (the measure goes down) | 4,084 people | ||||
| Liver Fibrosis | Improves (the measure goes down) | 4,084 people | ||||
| Triglycerides | Improves (the measure goes down) | 4,084 people |
Obesity
- Arterial Stiffness
- Glycemic Control: improves
- Insulin: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Arterial Stiffness No effect | NoneNo effect | 225 people | ||||
| Glycemic Control | Improves (the measure goes up) | 4 studies | 112 people | |||
| Insulin | Changes; see studies | 3 studies | 1 person | |||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 3 studies | 70 people | |||
| Blood glucose | Improves (the measure goes down) | 2 studies | 1 person | |||
| Blood Pressure | Improves (the measure goes down) | 2 studies | 225 people | |||
| Inflammation | Improves (the measure goes down) | 2 studies | 225 people | |||
| Weight | Improves (the measure goes down) | 2 studies | 307 people | |||
| HbA1c | Improves (the measure goes down) | 1 study | 1 person | |||
| Insulin Resistance | Improves (the measure goes down) | 1 study | 1 person | |||
| Muscle Mass | Improves (the measure goes up) | 1 study | 100 people | |||
| Parathyroid Hormone | Improves (the measure goes up) | 1 study | 100 people | |||
| Type 2 Diabetes Incidence | Changes; see studies | 1 study | 27,425 people | |||
| Body Fat | Improves (the measure goes down) | 184 people | ||||
| Body Mass Index (BMI) | Improves (the measure goes down) | 337 people | ||||
| Food Intake | Changes; see studies | 77 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 70 people | ||||
| Pulse Wave Velocity | Improves (the measure goes down) | 225 people | ||||
| Total cholesterol | Improves (the measure goes down) | 1 person | ||||
| Triglycerides | Improves (the measure goes down) | 93 people | ||||
| Vascular Function | Improves (the measure goes up) | 225 people | ||||
| Waist circumference | Improves (the measure goes down) | 290 people |
Overweight
- Arterial Stiffness
- Glycemic Control: improves
- Insulin: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Arterial Stiffness No effect | NoneNo effect | 225 people | ||||
| Glycemic Control | Improves (the measure goes up) | 4 studies | 89 people | |||
| Insulin | Changes; see studies | 3 studies | 181 people | |||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 3 studies | 70 people | |||
| Blood glucose | Improves (the measure goes down) | 2 studies | 225 people | |||
| Blood Pressure | Improves (the measure goes down) | 2 studies | 225 people | |||
| Inflammation | Improves (the measure goes down) | 2 studies | 225 people | |||
| Weight | Improves (the measure goes down) | 2 studies | 307 people | |||
| HbA1c | Improves (the measure goes down) | 1 study | 92 people | |||
| Insulin Resistance | Improves (the measure goes down) | 1 study | 225 people | |||
| Muscle Mass | Improves (the measure goes up) | 1 study | 77 people | |||
| Parathyroid Hormone | Improves (the measure goes up) | 1 study | 77 people | |||
| Testosterone | Improves (the measure goes up) | 1 study | 165 people | |||
| Body Fat | Improves (the measure goes down) | 184 people | ||||
| Body Mass Index (BMI) | Improves (the measure goes down) | 337 people | ||||
| Food Intake | Changes; see studies | 77 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 70 people | ||||
| Pulse Wave Velocity | Improves (the measure goes down) | 225 people | ||||
| Triglycerides | Improves (the measure goes down) | 93 people | ||||
| Vascular Function | Improves (the measure goes up) | 225 people | ||||
| Waist circumference | Improves (the measure goes down) | 290 people |
Asthma
- Acute Respiratory Tract Infection Symptoms
- Upper Respiratory Tract Infection Risk: changes; see studies
- Upper Respiratory Tract Infection Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Acute Respiratory Tract Infection Symptoms No effect | NoneNo effect | 2,461 people | ||||
| Upper Respiratory Tract Infection Risk | Changes; see studies | 13 studies | 3,958 people | |||
| Upper Respiratory Tract Infection Symptoms | Improves (the measure goes down) | 13 studies | 658 people | |||
| Asthma Symptoms | Improves (the measure goes down) | 2 studies | 2,461 people | |||
| Allergy Symptoms | Improves (the measure goes down) | 2,461 people | ||||
| Eczema Symptoms | Improves (the measure goes down) | 2,461 people | ||||
| Immunoglobulin E | Improves (the measure goes up) | 2,461 people | ||||
| Lung Function | Improves (the measure goes up) | 156 people |
Prediabetes
- Beta-cell function
- Glycemic Control: improves
- Insulin: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Beta-cell function No effect | NoneNo effect | 66 people | ||||
| Glycemic Control | Improves (the measure goes up) | 4 studies | 97 people | |||
| Insulin | Changes; see studies | 3 studies | 89 people | |||
| Insulin Resistance | Improves (the measure goes down) | 1 study | 66 people | |||
| Type 2 Diabetes Incidence | Changes; see studies | 1 study | 27,425 people |
Infertility
- Seminal Motility
- Sperm Count: improves
- Testosterone: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Seminal Motility No effect | NoneNo effect | |||||
| Sperm Count | Improves (the measure goes up) | 1 study | ||||
| Testosterone | Improves (the measure goes up) | 1 study | 449 people | |||
| Sex Hormone Binding Globulin | Improves (the measure goes up) | 449 people | ||||
| Sperm Quality | Improves (the measure goes up) |
Lower Respiratory Tract Infection
- Lower Respiratory Tract Infection Risk
- Upper Respiratory Tract Infection Risk: changes; see studies
- Upper Respiratory Tract Infection Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Lower Respiratory Tract Infection Risk No effect | NoneNo effect | 5,110 people | ||||
| Upper Respiratory Tract Infection Risk | Changes; see studies | 13 studies | 10,220 people | |||
| Upper Respiratory Tract Infection Symptoms | Improves (the measure goes down) | 13 studies | 156 people |
Eczema (Atopic Dermatitis)
- Acute Respiratory Tract Infection Symptoms
- Asthma Symptoms: improves
- Allergy Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Acute Respiratory Tract Infection Symptoms No effect | NoneNo effect | 2,461 people | ||||
| Asthma Symptoms | Improves (the measure goes down) | 2 studies | 2,461 people | |||
| Allergy Symptoms | Improves (the measure goes down) | 2,461 people | ||||
| Eczema Symptoms | Improves (the measure goes down) | 2,461 people | ||||
| Immunoglobulin E | Improves (the measure goes up) | 2,461 people |
Osteoarthritis (OA)
- Collagen Content
- Pain: improves
- Osteoarthritis Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Collagen Content No effect | NoneNo effect | 146 people | ||||
| Pain | Improves (the measure goes down) | 2 studies | 146 people | |||
| Osteoarthritis Symptoms | Improves (the measure goes down) | 146 people |
Respiratory Health
- Lower Respiratory Tract Infection Risk
- Upper Respiratory Tract Infection Risk: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Lower Respiratory Tract Infection Risk No effect | NoneNo effect | 5,724 people | ||||
| Upper Respiratory Tract Infection Risk | Changes; see studies | 13 studies | 5,724 people |
Multiple Sclerosis (MS)
- Multiple Sclerosis Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Multiple Sclerosis Symptoms | Improves (the measure goes down) | 6 studies | 719 people |
Fibromyalgia
- Fibromyalgia Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Fibromyalgia Symptoms | Improves (the measure goes down) | 4 studies | 176 people |
High Blood Pressure
- Blood Pressure: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood Pressure | Improves (the measure goes down) | 2 studies | 545 people |
Traumatic Brain Injury
- Inflammation: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Inflammation | Improves (the measure goes down) | 2 studies | 35 people |
Graves’ Disease
- Bone Mineral Density: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Bone Mineral Density | Improves (the measure goes up) | 2 studies | 86 people |
Acne
- Acne Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Acne Symptoms | Improves (the measure goes down) | 1 study | 44 people |
Alzheimer’s Disease
- Alzheimer's Disease Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Alzheimer's Disease Symptoms | Improves (the measure goes down) | 1 study | 210 people |
Chronic Obstructive Pulmonary Disease (COPD)
- Cathelicidin: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Cathelicidin | Improves (the measure goes up) | 1 study | 23 people |
Low Testosterone
- Testosterone: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Testosterone | Improves (the measure goes up) | 1 study | 165 people |
Type 1 Diabetes
- Type 1 Diabetes Incidence: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Type 1 Diabetes Incidence | Changes; see studies | 1 study | 51 people |
Cystic Fibrosis
- Bone turnover markers: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Bone turnover markers | Changes; see studies | 1 study | 91 people |
Diabetic Foot Ulcers
- Wound Healing: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Wound Healing | Improves (the measure goes up) | 1 study |
Frailty
- Fracture Risk: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Fracture Risk | Changes; see studies | 1 study | 42,279 people |
Longer Lifespan
- All-Cause Mortality: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| All-Cause Mortality | Improves (the measure goes down) | 1 study | 94,148 people |
Metabolic Health
- HbA1c: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| HbA1c | Improves (the measure goes down) | 1 study | 9 people |
Muscle Recovery
- Power Output: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Power Output | Improves (the measure goes up) | 1 study | 20 people |
Otitis Media
- Otitis Media Risk: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Otitis Media Risk | Changes; see studies | 1 study | 116 people |
Pancreatic Cancer
- Pancreatic Cancer Risk: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Pancreatic Cancer Risk | Changes; see studies | 1 study | 46 people |
Surgical Recovery
- Risk of Hypocalcemia: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Risk of Hypocalcemia | Improves (the measure goes up) | 1 study | 645 people |
Uremic Pruritus
- Itching: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Itching | Improves (the measure goes up) | 1 study | 1,085 people |
Thyroid Cancer
- Risk of Hypocalcemia: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Risk of Hypocalcemia | Improves (the measure goes up) | 1 study | 645 people |
Alzheimer’s Disease
- Alzheimer's Disease Symptoms: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Alzheimer's Disease Symptoms | Changes; see studies | 1 study | 210 people |
What the published studies found
6 automated readings
LDL cholesterol
The best available review (2024, 12 studies) found little or no difference in LDL cholesterol. That review studied patients with obesity or type 2 diabetes. 4 of the 6 studies read agree; 1 found no clear answer, 1 found an improvement. The evidence is limited.
6 studies counted of 9 read: 5 reviews and 1 trial (1,521 people in the trials).
- Meta-analysis, 2024; 12 studies; patients with obesity or type 2 diabetes: no clear difference (the review the verdict rests on).
had no effect on any of the outcomes analyzed
Effects of vitamin D supplementation on metabolic syndrome parameters in patients with obesity or diabetes in Brazil, Europe, and the United States: A systematic review and meta-analysis - Meta-analysis, 2026; 7 studies; patients with metabolic syndrome: no clear difference.
no significant differences were observed in
Effect of vitamin D supplementation on blood lipids in patients with metabolic syndrome: a meta-analysis - Meta-analysis, 2021; 9 studies; children and adolescents: no clear difference.
did not affect the changes of cardiometabolic risk markers
Effect of vitamin D supplementation on markers of cardiometabolic risk in children and adolescents: A meta-analysis of randomized clinical trials - Meta-analysis, 2016; 17 studies; patients with type 2 diabetes: improves.
significant lowering effect of vitamin D on LDL
Effects of vitamin D on serum lipid profile in patients with type 2 diabetes: A meta-analysis of randomized controlled trials - Meta-analysis, 2012; 12 studies, 1,346 people: unclear: evidence too weak to tell. Influence of vitamin D supplementation on plasma lipid profiles: a meta-analysis of randomized controlled trials
- Randomised trial, 2017; 1,521 people: no clear difference.
for LDL-C, compared with placebo, was -1.6
Effects of Calcium, Vitamin D, and Hormone Therapy on Cardiovascular Disease Risk Factors in the Women's Health Initiative: A Randomized Controlled Trial
- Meta-analysis, 2024; 12 studies; patients with obesity or type 2 diabetes: no clear difference (the review the verdict rests on).
Cardiovascular events
The best available review (2026, 9 studies, 114,379 people) found little or no difference in cardiovascular events. All 5 studies read agree. The evidence is moderate.
5 studies counted of 11 read: 5 reviews.
- Meta-analysis, 2026; 9 studies, 114,379 people: no clear difference (the review the verdict rests on).
vitamin D did not reduce any CVD events
Vitamin D supplementation and cardiovascular disease events: a systematic review and pooled meta-analysis of randomized clinical trials - Meta-analysis, 2024; 36 studies, 493,389 people: no clear difference.
no significant difference between vitamin D supplementation and placebo
Cardiovascular and Cerebrovascular Outcomes With Vitamin D Supplementation: A Systematic Review and Meta-Analysis - Meta-analysis, 2022: no clear difference.
no significant effects on the primary outcomes, including cancer, cardiovascular events
Critical Appraisal of Large Vitamin D Randomized Controlled Trials - Meta-analysis, 2020; 22 studies, 83,200 people: no clear difference.
CHD events (RR 1.00, CI 0.91-1.10)
Vitamin D supplementation, cardiac events and stroke: A systematic review and meta-regression analysis - Meta-analysis, 2019: no clear difference.
regarding CVD events and mortality from
Vitamin D and Cardiovascular Disease: An Update
- Meta-analysis, 2026; 9 studies, 114,379 people: no clear difference (the review the verdict rests on).
Mood
The 2 studies read (20,470 people in all) mostly found little or no difference in mood. The evidence is limited.
2 studies counted of 11 read: 2 trials (20,470 people in the trials).
- Randomised trial, 2020; 18,353 people; adults aged 50 years or older: no clear difference.
mean difference for change in mood scores, 0.01 points
Effect of Long-term Vitamin D3 Supplementation vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood Scores: A Randomized Clinical Trial - Randomised trial, 2006; 2,117 people; older women aged 70 years or more: no clear difference.
showed there was no significant difference between the two scores
Can vitamin D supplementation prevent winter-time blues? A randomised trial among older women
- Randomised trial, 2020; 18,353 people; adults aged 50 years or older: no clear difference.
Respiratory infections
A Cochrane review (2026, 107 studies, 31,521 people) found a small improvement in respiratory infections. That review studied children up to five years of age. 5 of the 8 studies read agree; 2 found no clear difference, 1 found no clear answer. The evidence is limited.
8 studies counted of 10 read: 5 reviews and 3 trials (540 people in the trials).
- Meta-analysis, 2026; 107 studies, 31,521 people; children up to five years of age: improves (the review the verdict rests on).
slight reduction in the proportion of children who make ARI-related healthcare visits
Vitamin D for preventing acute respiratory infections in children up to five years of age - Meta-analysis, 2025; 40 studies, 61,589 people: no clear difference.
did not statistically significantly affect overall ARI risk
Vitamin D supplementation to prevent acute respiratory infections: systematic review and meta-analysis of stratified aggregate data - Meta-analysis, 2025; 37 studies, 16,000 people: unclear: evidence too weak to tell.
SOR was 0.92 (0.86-0.99) for all trials
Vitamin D, acute respiratory infections, and Covid-19: The curse of small-size randomised trials. A critical review with meta-analysis of randomised trials - Systematic review, 2025; 38 studies; offspring of mothers given vitamin D in pregnancy: improves.
vitamin D supplementation reduced respiratory tract infections
Effects of Maternal Vitamin D Supplementation on Childhood Health - Meta-analysis, 2016; 4 studies, 3,198 people; children under five years of age: no clear difference.
episodes of 'radiologically confirmed' first or only episode of pneumonia were little different
Vitamin D supplementation for preventing infections in children under five years of age - Randomised trial, 2026; 80 people; ICU patients with traumatic lung contusion, VAP, sepsis: improves.
faster recovery from lung contusion, VAP, and sepsis
Effect of vitamin D as Nutrition Supplement on Patients with Prolonged Ventilation due to Ventilator Associated Pneumonia and Sepsis Followed Severe Traumatic Lung Contusion: A Randomized Controlled Trial - Randomised trial, 2025; 200 people; healthy 6-8-year-old children: improves.
had 17% fewer sick days due to ARTI
Effects of vitamin D supplementation on acute respiratory tract infections in 6-8-year-old children: a randomized clinical trial - Randomised trial, 2015; 260 people; pregnant women and their infants: improves.
proportion of children making any ARI visits was smaller in the higher-dose
Reduced primary care respiratory infection visits following pregnancy and infancy vitamin D supplementation: a randomised controlled trial
- Meta-analysis, 2026; 107 studies, 31,521 people; children up to five years of age: improves (the review the verdict rests on).
Sleep quality
The best available review (2022, 19 studies) found an improvement in sleep quality. 7 of the 8 studies read agree; 1 found a worse result. The evidence is moderate.
Possible harm: 1 study read reported a worse result for sleep quality with Vitamin D. One abstract says: "overall worse sleep quality (ptrend<0.01). Women who became vitamin D replete (≥32ng/mL) also showed a deterioration in total PSQI sleep quality score" Check the studies below, and ask a doctor or pharmacist if this applies to you.
8 studies counted of 10 read: 5 reviews and 3 trials (301 people in the trials).
- Meta-analysis, 2022; 19 studies: improves (the review the verdict rests on).
statistically significant decrease in the Pittsburgh Sleep Quality Index
Vitamin D Supplementation and Sleep: A Systematic Review and Meta-Analysis of Intervention Studies - Meta-analysis, 2022; 31 studies: improves. Efficacy of dietary supplements on improving sleep quality: a systematic review and meta-analysis
- Meta-analysis, 2022; 5 studies; people with poor sleep quality: improves.
significantly improves sleep quality (MD: -1.32; 95%CI: -2.55 to -0.09; P = 0.04)
The effect of vitamin D on sleep quality: A systematic review and meta-analysis - Meta-analysis, 2020; people with sleep disorders: improves. A meta-analysis: Does vitamin D play a promising role in sleep disorders?
- Meta-analysis, 2019; 2 studies; patients with psychiatric disorders: improves. The effects of vitamin D supplementation on mental health, and biomarkers of inflammation and oxidative stress in patients with psychiatric disorders: A systematic review and meta-analysis of randomized controlled trials
- Randomised trial, 2024; 212 people; chinese individuals with prediabetes: improves.
total PSQI score in vitamin D + calcium group was lower
Effects of vitamin D and/or calcium intervention on sleep quality in individuals with prediabetes: a post hoc analysis of a randomized controlled trial - Randomised trial, 2018; 89 people; 20-50 year-old people with sleep disorders: improves.
sleep score (PSQI) reduced significantly in vitamin recipients
The effect of vitamin D supplement on the score and quality of sleep in 20-50 year-old people with sleep disorders compared with control group - Randomised trial, 2016; overweight postmenopausal women with low vitamin D: worsens.
deterioration in total PSQI sleep quality score
Repletion of vitamin D associated with deterioration of sleep quality among postmenopausal women
- Meta-analysis, 2022; 19 studies: improves (the review the verdict rests on).
Stress
The best available review (2024, 6 studies, 445 people) found an improvement in stress. That review studied iranian women with polycystic ovary syndrome. 4 of the 6 studies read agree; 2 found no clear answer. The evidence is moderate.
6 studies counted of 11 read: 6 reviews.
- Meta-analysis, 2024; 6 studies, 445 people; iranian women with polycystic ovary syndrome: improves (the review the verdict rests on).
Vitamin D effectively reduced malondialdehyde (P=0.002)
Effects of vitamin D supplementation on oxidative stress biomarkers of Iranian women with polycystic ovary syndrome: a meta-analysis study - Systematic review, 2023; 11 studies; people undergoing exercise-induced muscle damage: unclear: evidence too weak to tell.
effects on muscle function, muscle pain and oxidative stress need to be confirmed
Effects of vitamin D supplementation on muscle function and recovery after exercise-induced muscle damage: A systematic review - Meta-analysis, 2022; 23 studies: improves. Efficacy of vitamin D supplementation as an adjunct therapy for improving inflammatory and oxidative stress biomarkers: An umbrella meta-analysis
- Meta-analysis, 2021; 18 studies, 1,060 people; patients with polycystic ovary syndrome: improves. Vitamin D improves levels of hormonal, oxidative stress and inflammatory parameters in polycystic ovary syndrome: a meta-analysis study
- Systematic review, 2019: unclear: evidence too weak to tell.
controversial effects about the ability of cholecalciferol
The controversial role of vitamin D as an antioxidant: results from randomised controlled trials - Meta-analysis, 2018; 7 studies; women with polycystic ovary syndrome: improves. The Effects of Vitamin D Supplementation on Biomarkers of Inflammation and Oxidative Stress Among Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- Meta-analysis, 2024; 6 studies, 445 people; iranian women with polycystic ovary syndrome: improves (the review the verdict rests on).
Key findings
- Fall RiskImproves (the measure goes down)
- Pre-Eclampsia RiskImproves (the measure goes down)
- Depression SymptomsImproves (the measure goes down)
Shop the evidence-backed picks
Fullscript collections
Fullscript collectionStress and mood: evidence-graded picksOpen on FullscriptFullscript collectionMuscle, performance and healthy ageing: evidence-graded picksOpen on FullscriptFullscript collectionJoints and bones: evidence-graded picksOpen on FullscriptFullscript collectionImmune support: evidence-graded picksOpen on FullscriptEach collection holds the supplements we grade A or B for its theme, in third-party tested products where the catalog has them. It opens in our Fullscript store. You can look through it without signing in; Fullscript asks for a free account to order.
Or shop one supplement
Third-party tested Vitamin D products, in the forms the graded studies used where we can match them.
- Grade A
We earn from purchases made in our Fullscript store, and links to Fullscript, iHerb or Thorne carry our referral, so we may earn a commission at no extra cost to you. Grades come from the research and never change based on what we earn. Full disclosure
Studies cited
100 studies from PubMed
- Effect of vitamin D supplementation for major adverse cardiovascular events: a meta-analysis based on randomised controlled trials.
- Optimal Vitamin D Status: Evidence and Guidelines
- Vitamin D and Cancer Prevention: A Comprehensive Review
- Effects of Vitamin D Supplementation on Musculoskeletal Health: A Systematic Review and Meta-Analysis
- Vitamin D and Prevention of Respiratory Tract Infections: A Systematic Review and Meta-Analysis
- Effects of Vitamin D Supplementation on Depression: A Systematic Review and Meta-Analysis
- Vitamin D and Immune Function: A Review
- Vitamin D Supplementation for Prevention of Mortality: A Meta-Analysis
- Vitamin D Supplementation During Pregnancy: Safety and Efficacy Review
- Vitamin D Supplementation: A Comprehensive Review of Efficacy for Various Health Outcomes
- Vitamin D Deficiency: Global Health Perspective
- Vitamin D and Cardiovascular Disease: A Review of Evidence
- Vitamin D and Bone Health in Adults: A Systematic Review
- Vitamin D3 supplementation does not modify cardiovascular risk profile of adults with inadequate vitamin D status
- Association of A1C levels with vitamin D status in U.S. adults: data from the National Health and Nutrition Examination Survey
- Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey
- Effects of selected dietary supplements on migraine prophylaxis: A systematic review and dose-response meta-analysis of randomized controlled trials.
- Safety, tolerability, and efficacy of orally administered cannabinoids in MS
- Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial
- The effect of cannabis on tremor in patients with multiple sclerosis
- Supplementation with vitamin D or ω-3 fatty acids in adolescent girls and young women with endometriosis (SAGE): a double-blind, randomized, placebo-controlled trial
- Double-blind randomised placebo-controlled trial of bolus-dose vitamin D3 supplementation in adults with asthma (ViDiAs)
- Vitamin D Supplementation and the Risk of Colds in Patients with Asthma
- Association between prenatal vitamin D supplementation and respiratory diseases in children: a systematic review and meta-analysis.
- Vitamin D supplementation decrease asthma exacerbations in children: a systematic review and meta-analysis of randomized controlled trials.
- The effects of prenatal vitamin D supplementation on respiratory and allergy-related outcomes in children: A systematic review and meta-analysis of randomized controlled trials.
- Effects of Vitamin D on Endometriosis-Related Pain: A Double-Blind Clinical Trial
- The effect of vitamin D supplementation on clinical symptoms and metabolic profiles in patients with endometriosis
- Vitamin D for primary dysmenorrhea and endometriosis-related pain - A systematic review of registered RCTs.
- High-Dose Monthly Vitamin D for Prevention of Acute Respiratory Infection in Older Long-Term Care Residents: A Randomized Clinical Trial
- Randomized trial of vitamin D supplementation and risk of acute respiratory infection in Mongolia
- Reduced primary care respiratory infection visits following pregnancy and infancy vitamin D supplementation: a randomised controlled trial
- Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis
- Therapeutic effect of vitamin D3 in multiple sclerosis patients
- Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial
- Relationship between 25-OH-D serum level and relapse rate in multiple sclerosis patients before and after vitamin D supplementation
- Randomized trial of daily high-dose vitamin D 3 in patients with RRMS receiving subcutaneous interferon β-1a
- Cholecalciferol in relapsing-remitting MS: A randomized clinical trial (CHOLINE)
- Effects of adjunct low-dose vitamin d on relapsing-remitting multiple sclerosis progression: preliminary findings of a randomized placebo-controlled trial
- Vitamin D supplementation and upper respiratory tract infections in adolescent swimmers: a randomized controlled trial
- Effect of vitamin D3 supplementation on upper respiratory tract infections in healthy adults: the VIDARIS randomized controlled trial
- Vitamin D3 and gargling for the prevention of upper respiratory tract infections: a randomized controlled trial
- Intake of 25-Hydroxyvitamin D3 Reduces Duration and Severity of Upper Respiratory Tract Infection: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Comparison Study
- Vitamin D₃ Supplementation Reduces the Symptoms of Upper Respiratory Tract Infection during Winter Training in Vitamin D-Insufficient Taekwondo Athletes: A Randomized Controlled Trial
- A randomized controlled trial of vitamin D3 supplementation for the prevention of symptomatic upper respiratory tract infections
- Vitamin D supplementation for the prevention of acute respiratory tract infection: a randomized, double-blinded trial among young Finnish men
- Effect of High-Dose vs Standard-Dose Wintertime Vitamin D Supplementation on Viral Upper Respiratory Tract Infections in Young Healthy Children
- Vitamin D supplementation to prevent infections: a sub-study of a randomised placebo-controlled trial in older people (RECORD trial, ISRCTN 51647438)
- Vitamin D3 supplementation and upper respiratory tract infections in a randomized, controlled trial
- Effect of monthly high-dose vitamin D supplementation on acute respiratory infections in older adults: A randomized controlled trial
- Vitamin D3 supplementation in patients with frequent respiratory tract infections: a randomised and double-blind intervention study
- Effect of Vitamin D supplementation to reduce respiratory infections in children and adolescents in Vietnam: A randomized controlled trial
- Winter cholecalciferol supplementation at 55°N has little effect on markers of innate immune defense in healthy children aged 4-8 years: a secondary analysis from a randomized controlled trial
- Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers
- Different doses of supplemental vitamin D maintain interleukin-5 without altering skeletal muscle strength: a randomized, double-blind, placebo-controlled study in vitamin D sufficient adults
- Vitamin D, tuberculin skin test conversion, and latent tuberculosis in Mongolian school-age children: a randomized, double-blind, placebo-controlled feasibility trial
- Double-blind randomised controlled trial of vitamin D3 supplementation for the prevention of acute respiratory infection in older adults and their carers (ViDiFlu)
- Effects of vitamin D supplementation to children diagnosed with pneumonia in Kabul: a randomised controlled trial
- Vitamin D supplementation for severe pneumonia--a randomized controlled trial
- Systematic review: Vitamin D and calcium supplementation in prevention of cardiovascular events
- Effect of vitamin D supplementation on progression of knee pain and cartilage volume loss in patients with symptomatic osteoarthritis: a randomized controlled trial
- Impact of vitamin D supplementation during a resistance training intervention on body composition, muscle function, and glucose tolerance in overweight and obese adults
- A randomized, placebo-controlled trial of vitamin D supplementation to improve glycaemia in overweight and obese African Americans
- A 12-week double-blind randomized clinical trial of vitamin D3 supplementation on body fat mass in healthy overweight and obese women
- Can Vitamin D supplementation enhance the effectiveness of exercise-induced weight loss in overweight or obese adults? Evidence from integrated transcriptomic and meta-analysis
- Effect of vitamin D supplementation on body composition, lipid profile, and glycemic indices in patients with obesity-associated metabolic syndrome: a systematic review and meta-analysis.
- Effect of vitamin D3 supplementation on vascular and metabolic health of vitamin D-deficient overweight and obese children: a randomized clinical trial.
- Vitamin D supplementation vs. placebo and incident type 2 diabetes in an ancillary study of the randomized Vitamin D and Omega-3 Trial.
- Effects of vitamin D on patients with fibromyalgia syndrome: a randomized placebo-controlled trial
- Vitamin D Supplementation Seems to Improve Fibromyalgia Symptoms: Preliminary Results
- Effects of Vitamin D Therapy on Quality of Life in Patients with Fibromyalgia
- Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren
- Preventive Effects of Vitamin D on Seasonal Influenza A in Infants: A Multicenter, Randomized, Open, Controlled Clinical Trial
- Vitamin D supplementation did not prevent influenza-like illness as diagnosed retrospectively by questionnaires in subjects participating in randomized clinical trials
- Effects of vitamin D supplements on influenza A illness during the 2009 H1N1 pandemic: a randomized controlled trial
- Effects of vitamin D and calcium supplementation on pancreatic β cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial
- Effect of vitamin D supplementation on testosterone levels in men
- Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality
- Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19: A Randomized Clinical Trial
- Effects of a 2-Week 5000 IU versus 1000 IU Vitamin D3 Supplementation on Recovery of Symptoms in Patients with Mild to Moderate Covid-19: A Randomized Clinical Trial
- "Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study"
- Therapeutic effects of vitamin D supplementation on COVID-19 aggravation: a systematic review and meta-analysis of randomized controlled trials.
- Vitamin D supplementation for managing COVID-19 in patients with vitamin D deficiency: a systematic review and meta-analysis of randomised controlled trials.
- Effect of vitamin D supplementation on clinical outcomes in adult patients with COVID-19: A GRADE-assessed systematic review and meta-analysis of randomized controlled trials.
- The Effect of Vitamin D Supplementation Post COVID-19 Infection and Related Outcomes: A Systematic Review and Meta-Analysis.
- Vitamin D and prevention of breast cancer: pooled analysis
- Association between plasma 25-hydroxyvitamin D and breast cancer risk
- Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer
- A prospective randomized controlled trial of the effects of vitamin D supplementation on cardiovascular disease risk
- The effect of vitamin D supplement on the score and quality of sleep in 20-50 year-old people with sleep disorders compared with control group
- Correlation of symptoms with vitamin D deficiency and symptom response to cholecalciferol treatment: a randomized controlled trial
- Efficacy of vitamin D supplementation on depressive symptoms in older patients: a meta-analysis of randomized controlled trials.
- Effect of vitamin D supplementation, directly or via breast milk for term infants, on serum 25 hydroxyvitamin D and related biochemistry, and propensity to infection: a randomised placebo-controlled trial
- Supplementation with 1000 IU vitamin D/d leads to parathyroid hormone suppression, but not increased fractional calcium absorption, in 4-8-y-old children: a double-blind randomized controlled trial
- Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials
- Changes in bone turnover after high-dose vitamin D supplementation during acute pulmonary exacerbation in cystic fibrosis.
- Vitamin D Supplementation for Premenstrual Syndrome-Related inflammation and antioxidant markers in students with vitamin D deficient: a randomized clinical trial
- The Effect of Vitamin D Supplement Consumption on Premenstrual Syndrome in Vitamin D-Deficient Young Girls: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
- Vitamin D Supplementation for Premenstrual Syndrome-Related Mood Disorders in Adolescents with Severe Hypovitaminosis D
- High dose vitamin D supplementation can improve menstrual problems, dysmenorrhea, and premenstrual syndrome in adolescents